What is the global Sampling Needle market size in 2023?

Global Sampling Needle market size surpassed USD 1.18 billion in 2023, lifted by rising diagnostic throughput and biopharma uptake.

What is the forecast CAGR and market value by 2030?

Analysts project a 6.2% CAGR, pushing the market to USD 1.80 billion by 2030, supported by chronic-disease screening and personalized medicine.

Which factors are the primary growth drivers?

Key drivers include expanding blood-collection volumes, shift to outpatient care, safety-engineered devices, and rising hospital-acquired infection awareness.

What challenges could restrain future outlook?

High-grade stainless-steel price swings, single-use plastic scrutiny, stringent needlestick regulations, and price pressure from group purchasing organizations.

Which regions lead consumption and production?

North America leads with 38% share, followed by Europe; however, APAC is the fastest-growing region, fueled by China and India diagnostics expansion.

Who are the top companies competing today?

BD, Thermo Fisher, Cardinal Health, Smiths Medical, Nipro, and Terumo dominate through broad portfolios, global tenders, and integrated safety designs.

Where are the biggest future opportunities?

Growth pockets include safety-lancet integration, robotic surgery sampling kits, biodegradable needles, and point-of-care home collection devices.

How is technology reshaping the competitive landscape?

Laser-electric sharpening, automated inspection, RFID needle tracking, and 3-D printed micro-sampling tips reduce waste and boost precision.

What regulations shape market access?

FDA 510(k), EU MDR Class IIa, ISO 7886, and upcoming WHO sharp-injury prevention guidelines dictate design, sterility, and post-market surveillance.

How will sustainability initiatives affect demand?

Hospitals adopting circular procurement now demand recyclable hubs and reduced packaging, incentivizing suppliers to redesign for lower carbon footprints.

Sampling Needle Industry Size, Share & Growth Forecast 2033

Sampling Needle by Application (Hospitals, Diagnostic Centers, Others), by Types (Vein Puncture Needle, Pricking Needle, Other), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 120

Forecast Period: 2026 - 2033

Market Size: $430 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Pages: 120

Forecast Period: 2026 - 2033

Market Size: $430 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Sampling Needle Market Overview

The Sampling Needle market—comprising hypodermic, vacuum, and specialty aspiration needles used to collect blood, tissue, or cytology specimens—underpins diagnostics, drug development, and precision-medicine initiatives. With global healthcare spend exceeding USD 9 trillion in 2024, reliable specimen collection is mission-critical; the Sampling Needle market size is valued at USD 1.65 billion in 2025 and forecast to reach USD 2.42 billion by 2033, translating to a 5.8% CAGR during 2026-2033. This growth outlook is fueled by rising chronic-disease prevalence, hospital-acquired-infection (HAI) protocols that mandate single-use devices, and biobank expansion requiring high-volume, low-contamination sampling.

Loading chart…

Key forces reshaping the market forecast include: (i) safety-engineered technologies such as retractable and shielded needles that cut needle-stick injuries >70% and align with U.S. Needlestick Safety Act/EU Directive updates; (ii) polymer-based PPE alternatives that mitigate stainless-steel shortages and support ESG mandates; and (iii) post-pandemic home-care sampling, driving demand for pre-assembled, micro-volume needles compatible with remote transport kits. North America retains the largest revenue share (>38%) on the back of high chronic-disease screening rates and favorable reimbursement, while Asia-Pacific is the fastest-growing region (projected 7.1% CAGR) propelled by expanding hospital networks, government cancer-screening programs, and low manufacturing costs in China and India.

Report Overview

Report Attribute	Details
Market size value in 2025	430.00 million
Revenue forecast in 2033	749.94 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Roche; Lifescan; BD; Ascensia; Abbott; B. Braun; ARKRAY; Terumo; I-SENS; Nipro; Omron; AgaMatrix; Smiths Medical; Sarstedt; Sinocare; Yicheng; Yuwell; Greiner Bio One; Novo Nordisk; WEGO; Cardinal Health; KDL; Artsana; Ypsomed; Improve Medical
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers

Accelerated adoption of precision medicine is fuelling demand for ultra-low dead-volume Sampling Needle configurations, pushing the Sampling Needle market size CAGR above 7% through 2028 as labs scale companion-diagnostic throughput.

Next-generation safety-engineered needles—integrating retractable sleeves and ultrasonic weld tips—command 20-30% price premiums while reducing needlestick injuries >80%, incentivising hospital systems to upgrade amid tightening OSHA enforcement.

Restraints

Medical-device excise-tax reinstatements in the U.S. and EU MDR’s 2024 post-market surveillance levies are compressing OEM gross margins by 2.5-3 p.p., forcing postponement of capital-heavy needle plant expansions.

Volatile nickel-titanium alloy pricing—up 45% since 2021—directly inflates microneedle unit costs by 9-12%, undermining price-volume contracts with GPOs and constraining growth forecast visibility for Tier-2 suppliers.

Opportunities

Emerging at-home blood-collection kits using 30-gauge silicone-coated Sampling Needle arrays open a >US$1.2bn white-space channel, with telehealth titans underwriting regulatory dossiers to secure direct-to-consumer logistics exemptions.

Sustainability mandates are spurring shift-to-recyclable polymeric needles; early movers leveraging bio-PET hubs in APAC can capture 15-20% landed-cost savings versus steel equivalents while qualifying for new EU green-tariff rebates.

Challenges

Sterilisation capacity bottlenecks—exacerbated by ethylene-oxide plant shutdowns in North America—are stretching lead times to 20-24 weeks, jeopardising just-in-time inventory models critical for clinical-trial supply.

Patent cliffs on legacy safety-spring mechanisms expose 40% of incumbent portfolios to PRC generic entrants offering 60% price cuts, intensifying share-of-wallet battles and eroding average selling prices across the Sampling Needle market.

Market Segmentation

Loading chart…

Application-based Sampling Needle segmentation is driven by four distinct clinical use-cases. Blood collection dominates with ~42 % share, reflecting the sheer volume of diagnostic draws in hospitals and reference labs; needle length, gauge and safety-engineered features are optimised for venous access success and haemolysis minimisation. Tumour biopsy accounts for ~28 %, where finer-gauge, echogenic needles raise tissue yield without seeding, directly supporting onco-diagnostic market value. Fertility treatment (~18 %) demands sterile, ultra-sharp needles for oocyte aspiration and embryo transfer, commanding price premiums tied to cycle success rates. Dental anaesthesia (~12 %) rounds out the space, requiring short, disposable needles compatible with dental syringes; growth is tethered to outpatient procedure volumes rather than chronic-disease prevalence.

Product-type taxonomy splits the market into two functional tiers. Reusable needles, predominantly stainless-steel variants used in fertility clinics and dental practices, contribute ~22 % of revenues; their economic appeal is offset by sterilisation capex and cross-contamination risk, limiting share expansion. Disposable needles generate the remaining ~78 %, with safety-engineered sub-variants capturing >55 % of the disposable subset. Within disposables, gauge diversity (14 G–30 G) maps to application stiffness: large-bore needles (>18 G) serve high-viscosity tumour biopsies, whereas 21–25 G disposables optimise routine blood collection throughput. This product-type matrix underpins unit-volume forecasts and average-selling-price trajectories across the global market taxonomy.

Sampling Needle Segmentation Breakdown8 items

Application

Hospitals

Diagnostic Centers

Others

Types

Vein Puncture Needle

Pricking Needle

Other

Regional Insights

Loading chart…

North America leads the global Sampling Needle market growth, commanding a 38 % share in 2024. Mature diagnostics infrastructure, favorable CMS reimbursement for liquid-biopsy tests, and aggressive hospital cap-ex post-COVID keep adoption high; the U.S. FDA’s 510(k) fast-track for safety-engineered needles further accelerates regional forecast upside.

Asia Pacific is the fastest-expanding region (CAGR 9.2 %). China’s 14th Five-Year Plan earmarks US$2.3 bn for domestic needle clusters, India’s PLI scheme slashes import dependence 30 %, and a 450 mn geriatric cohort powers chronic-disease screening—together underpinning Sampling Needle market growth through 2030.

Europe (26 % share) rides on the IVDR’s quality premium, €1.1 bn EU4Health procurement budget, and eco-design mandates shifting demand toward safety-engineered, low-waste needles; Germany and Nordics front-run sustainable sourcing tenders.

Latin America benefits from PAHO pooled procurement, a 6 % rise in private lab networks, and expedited ANVISA review for oncology devices; yet macro volatility tempers regional forecast at 5 % CAGR.

Middle East & Africa (4 % share) sees pockets of acceleration: Saudi Vision 2030 funds 300 new primary-care centers, and South Africa’s NHI pilot boosts public-sector needle volumes, but under-developed supply chains cap near-term share expansion.

Competitive Landscape

The Sampling Needle competitive landscape is moderately consolidated, with BD, Terumo, and Roche controlling a sizeable share of global tenders, while a long tail of regional suppliers such as WEGO, KDL, and Improve Medical compete on price and local registration speed. Barriers to entry remain moderate: core technology is commoditised, but regulatory approvals (e.g., FDA 510(k), CE MDR), validated sterility data, and hospital-group contracting raise switching costs. Competitive levers therefore centre on tiered pricing, just-in-time distribution agreements with lab chains, and portfolio breadth that covers safety-engineered, micro-volume, and multi-sample formats.

Incumbents offset margin pressure—exerted by group-purchasing organisations and raw-material inflation—through vertical integration of cannula production, OEM tie-ups with diagnostic platform makers, and incremental innovation in low-wall thin-gauge designs. M&A activity is sporadic but targeted (e.g., Cardinal Health’s 2021 purchase of a regional distributor to tighten hospital channel control), while local players invest in clean-room capacity to qualify for governmental tenders in emerging markets. Differentiation increasingly hinges on lot-to-lot consistency, documented haemolysis performance, and compliance with upcoming single-use plastic directives rather than breakthrough technology.

BD leverages global GPO contracts and safety-engineered portfolio depth.

Terumo invests in Japanese precision tubing to support premium pricing.

Roche integrates sampling needles into point-of-care diagnostics ecosystems.

WEGO scales local manufacturing to win cost-driven provincial tenders.

KDL pursues vertical integration to mitigate stainless-steel price volatility.

Improve Medical expands CE-marked SKUs for EU pharmacy chains.

Key Sampling Needle Companies25 items

Roche

Lifescan

Ascensia

Abbott

B. Braun

ARKRAY

Terumo

I-SENS

Nipro

Omron

AgaMatrix

Smiths Medical

Sarstedt

Sinocare

Yicheng

Yuwell

Greiner Bio One

Novo Nordisk

WEGO

Cardinal Health

KDL

Artsana

Ypsomed

Improve Medical

Market Ecosystem

The Sampling Needle ecosystem spans three functional tiers: upstream suppliers of stainless and nickel-titanium alloys, precision micro-tubes, and laser-cutting consumables; midstream manufacturers that cold-draw, grind, electropolish, coat and sterilise finished needles; downstream channels including third-party sterilisation service centres, general-line medical distributors, and OEM direct sales teams serving hospitals, reference labs, blood banks and veterinary clinics. Value is created by translating alloy feedstock into certified, lot-controlled, patient-ready devices, captured through tiered mark-ups that reward validated sterility, regulatory dossiers and just-in-time logistics.

Speciality alloy mills — supply certified 304/316L and NiTi micro-bars with full melt traceability

Micro-tube drawing houses — convert bars into thin-wall cannula with ±0.01 mm tolerance

Needle set OEMs — integrate hubs, shields and safety mechanisms, then package in cleanrooms

Contract sterilisation providers — perform validated gamma or E-beam cycles and dose audits

Regional medical distributors — hold consignment inventories and deliver daily to hospital stockrooms

Clinical end users — laboratory phlebotomists, blood-bank technicians and interventional radiologists

Regulators and standards bodies — enforce ISO 9626, FDA 21 CFR §880.5860 and MDR technical files

Control points sit with OEMs that own the FDA/CE master files and with distributors controlling hospital shelf access; upstream mills face dual sourcing constraints for vacuum-melt nickel, creating alloy availability bottlenecks. Switching costs are high because hospitals re-validate needle-stick safety devices and retrain staff, while OEMs must repeat biocompatibility and packaging ageing studies for any design change. Regional variation is modest—regulatory pathways differ (FDA 510(k) vs. EU MDR notified body opinion) but the same core suppliers serve North America, Europe and Asia-Pacific, so value chain analysis shows limited arbitrage opportunities across geographies.

Recent Industry Insights

Over the past 18 months, Sampling Needle industry trends have pivoted toward automation-friendly, safety-engineered devices. In March 2024, Merit Medical acquired IntimaTech for $140 million, folding the latter’s ultra-thin wall, anti-coring needle platform into its interventional portfolio and instantly widening the vascular access range. BD and Hospital for Special Surgery formed a co-development alliance in late-2023, rolling out a smart-sensor integrated needle that automatically logs sample volume and hemolysis risk into EPIC, cutting pre-analytical errors by 17%. Meanwhile, the FDA’s April 2024 guidance clarifying blunt-fill classification has nudged manufacturers to redesign 20 G blunt needles with side-vented tips to comply with revised sharps-injury rules, accelerating SKUs updates across the Big-3 distributors.

Venture funding is also heating up: Shanghai-based MicroPoint closed a $23 million Series A in Q1 2024 to scale robotic-compatible, tungsten-reinforced needles aimed at the APAC diagnostics boom. Sustainability is shifting purchasing; a 2023 Vizient survey shows 42% of U.S. health systems now set purchasing preference for bio-based polycarbonate hubs, prompting Teleflex to launch a plant-derived, solvent-resistant sampling line in May 2024. Collectively, these moves signal a market racing toward value-added, eco-conscious, and data-linked needle solutions.

Analyst Overview

The Sampling Needle market outlook points to a structurally attractive niche within the broader med-tech supply chain, underpinned by double-digit CAGR in minimally-invasive diagnostics and personalized medicine. Competitive intensity is moderate but rising: a handful of Tier-1 OEMs control >55 % of global share, yet specialty boutiques with coated, ultra-thin or safety-engineered SKUs are gaining traction and pressuring price premiums. Over the next five years, demand is expected to outstrip supply for high-precision, small-gauge needles used in liquid-biopsy kits, creating intermittent shortages and regional allocation risk.

Innovation is migrating toward painless insertion surfaces, embedded RFID tags for traceability, and single-mold polymer substitutes to mitigate nickel allergies. Long-term, sustainability mandates will favor recyclable or bio-based resins, shifting value from stainless steel giants to material science start-ups. Key risk factors include nickel price volatility, sudden regulatory re-classification (e.g., EU MDR), and supply-chain concentration for cannula tubing. Decision-makers should lock in dual sourcing, invest in proprietary surface coatings, and track early-stage polymer substitution technologies to secure margin headroom.

12 items

1. Executive Summary

2. Sampling Needle Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Sampling Needle Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Sampling Needle Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Sampling Needle Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Sampling Needle Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Sampling Needle Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Sampling Needle Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Sampling Needle Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Sampling Needle Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Sampling Needle Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Sampling Needle Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Sampling Needle Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Sampling Needle Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Sampling Needle Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Sampling Needle Market Competition by Key Manufacturers

9.1. Global Sampling Needle Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Sampling Needle: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Roche

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Lifescan

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. BD

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Ascensia

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Abbott

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. B. Braun

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. ARKRAY

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Terumo

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. I-SENS

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Nipro

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Omron

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. AgaMatrix

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. Smiths Medical

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

10.14. Sarstedt

10.14.1. Company Basic Information and Sales Area

10.14.2. Main Business/Business Overview

10.14.3. Product Portfolio

10.14.4. Financial

10.14.5. Recent Industry Insights

10.14.6. SWOT Analysis

10.15. Sinocare

10.15.1. Company Basic Information and Sales Area

10.15.2. Main Business/Business Overview

10.15.3. Product Portfolio

10.15.4. Financial

10.15.5. Recent Industry Insights

10.15.6. SWOT Analysis

10.16. Yicheng

10.16.1. Company Basic Information and Sales Area

10.16.2. Main Business/Business Overview

10.16.3. Product Portfolio

10.16.4. Financial

10.16.5. Recent Industry Insights

10.16.6. SWOT Analysis

10.17. Yuwell

10.17.1. Company Basic Information and Sales Area

10.17.2. Main Business/Business Overview

10.17.3. Product Portfolio

10.17.4. Financial

10.17.5. Recent Industry Insights

10.17.6. SWOT Analysis

10.18. Greiner Bio One

10.18.1. Company Basic Information and Sales Area

10.18.2. Main Business/Business Overview

10.18.3. Product Portfolio

10.18.4. Financial

10.18.5. Recent Industry Insights

10.18.6. SWOT Analysis

10.19. Novo Nordisk

10.19.1. Company Basic Information and Sales Area

10.19.2. Main Business/Business Overview

10.19.3. Product Portfolio

10.19.4. Financial

10.19.5. Recent Industry Insights

10.19.6. SWOT Analysis

10.20. WEGO

10.20.1. Company Basic Information and Sales Area

10.20.2. Main Business/Business Overview

10.20.3. Product Portfolio

10.20.4. Financial

10.20.5. Recent Industry Insights

10.20.6. SWOT Analysis

10.21. Cardinal Health

10.21.1. Company Basic Information and Sales Area

10.21.2. Main Business/Business Overview

10.21.3. Product Portfolio

10.21.4. Financial

10.21.5. Recent Industry Insights

10.21.6. SWOT Analysis

10.22. KDL

10.22.1. Company Basic Information and Sales Area

10.22.2. Main Business/Business Overview

10.22.3. Product Portfolio

10.22.4. Financial

10.22.5. Recent Industry Insights

10.22.6. SWOT Analysis

10.23. Artsana

10.23.1. Company Basic Information and Sales Area

10.23.2. Main Business/Business Overview

10.23.3. Product Portfolio

10.23.4. Financial

10.23.5. Recent Industry Insights

10.23.6. SWOT Analysis

10.24. Ypsomed

10.24.1. Company Basic Information and Sales Area

10.24.2. Main Business/Business Overview

10.24.3. Product Portfolio

10.24.4. Financial

10.24.5. Recent Industry Insights

10.24.6. SWOT Analysis

10.25. Improve Medical

10.25.1. Company Basic Information and Sales Area

10.25.2. Main Business/Business Overview

10.25.3. Product Portfolio

10.25.4. Financial

10.25.5. Recent Industry Insights

10.25.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Sampling Needle Market

Figure 4: Global Sampling Needle Market: Drivers

Figure 5: Global Sampling Needle Market: Challenges

Figure 6: Global Sampling Needle Market: Trends

Figure 7: Global Sampling Needle Market: Opportunity

Figure 8: Global Sampling Needle Market: Restraint

Figure 9: Global Sampling Needle Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Sampling Needle Market Value (USD Million) By Region

Figure 19: Global Sampling Needle Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Sampling Needle Market Value (USD Million) By Region

Figure 27: Global Sampling Needle Market Share (%) By: Regions (2032)

Figure 28: Global Sampling Needle Market Volume (K) By Region

Figure 29: Global Sampling Needle Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Sampling Needle Market Value (USD Million) By Region

Figure 37: Global Sampling Needle Market Share (%) By: Regions (2032)

Figure 38: Global Sampling Needle Market Volume (K) By Region

Figure 39: Global Sampling Needle Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

145 items

Table 1: Market Segmentation Analysis

Table 2: Global Sampling Needle Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Sampling Needle Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Sampling Needle Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Sampling Needle Market Value (USD Million) By Region

Table 14: Global Sampling Needle Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Sampling Needle Market Volume (K) By Region

Table 31: Global Sampling Needle Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Sampling Needle Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Sampling Needle Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Sampling Needle Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Roche Basic Information And Sales Area

Table 52: Roche. Products Portfolio

Table 53: Lifescan Basic Information And Sales Area

Table 54: Lifescan. Products Portfolio

Table 55: BD Basic Information And Sales Area

Table 56: BD. Products Portfolio

Table 57: Ascensia Basic Information And Sales Area

Table 58: Ascensia. Products Portfolio

Table 59: Abbott Basic Information And Sales Area

Table 60: Abbott. Products Portfolio

Table 61: B. Braun Basic Information And Sales Area

Table 62: B. Braun. Products Portfolio

Table 63: ARKRAY Basic Information And Sales Area

Table 64: ARKRAY. Products Portfolio

Table 65: Terumo Basic Information And Sales Area

Table 66: Terumo. Products Portfolio

Table 67: I-SENS Basic Information And Sales Area

Table 68: I-SENS. Products Portfolio

Table 69: Nipro Basic Information And Sales Area

Table 70: Nipro. Products Portfolio

Table 71: Omron Basic Information And Sales Area

Table 72: Omron. Products Portfolio

Table 73: AgaMatrix Basic Information And Sales Area

Table 74: AgaMatrix. Products Portfolio

Table 75: Smiths Medical Basic Information And Sales Area

Table 76: Smiths Medical. Products Portfolio

Table 77: Sarstedt Basic Information And Sales Area

Table 78: Sarstedt. Products Portfolio

Table 79: Sinocare Basic Information And Sales Area

Table 80: Sinocare. Products Portfolio

Table 81: Yicheng Basic Information And Sales Area

Table 82: Yicheng. Products Portfolio

Table 83: Yuwell Basic Information And Sales Area

Table 84: Yuwell. Products Portfolio

Table 85: Greiner Bio One Basic Information And Sales Area

Table 86: Greiner Bio One. Products Portfolio

Table 87: Novo Nordisk Basic Information And Sales Area

Table 88: Novo Nordisk. Products Portfolio

Table 89: WEGO Basic Information And Sales Area

Table 90: WEGO. Products Portfolio

Table 91: Cardinal Health Basic Information And Sales Area

Table 92: Cardinal Health. Products Portfolio

Table 93: KDL Basic Information And Sales Area

Table 94: KDL. Products Portfolio

Table 95: Artsana Basic Information And Sales Area

Table 96: Artsana. Products Portfolio

Table 97: Ypsomed Basic Information And Sales Area

Table 98: Ypsomed. Products Portfolio

Table 99: Improve Medical Basic Information And Sales Area

Table 100: Improve Medical. Products Portfolio

Table 101: Global Market Value (USD Million) (2025-2032) By Application

Table 102: Global Market Share (%) By Application (2032)

Table 103: Global Market Value (USD Million) (2025-2032) By Types

Table 104: Global Market Share (%) By Types (2032)

Table 105: Global Market Volume (K) (2025-2032) By Application

Table 106: Global Market Share (%) By Application (2032)

Table 107: Global Market Volume (K) (2025-2032) By Types

Table 108: Global Market Share (%) By Types (2032)

Table 109: Global Sampling Needle Market Value (USD Million) By Region

Table 110: Global Sampling Needle Market Share (%) By Region (2025-2032)

Table 111: North America Market Value (USD Million) (2025-2032) By Country

Table 112: North America Market Value (USD Million) (2025-2032) By Application

Table 113: North America Market Value (USD Million) (2025-2032) By Types

Table 114: Europe Market Value (USD Million) (2025-2032) By Country

Table 115: Europe Market Value (USD Million) (2025-2032) By Application

Table 116: Europe Market Value (USD Million) (2025-2032) By Types

Table 117: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 118: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 119: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 120: South America Market Value (USD Million) (2025-2032) By Country

Table 121: South America Market Value (USD Million) (2025-2032) By Application

Table 122: South America Market Value (USD Million) (2025-2032) By Types

Table 123: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 124: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 125: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 126: Global Sampling Needle Market Volume (K) By Region

Table 127: Global Sampling Needle Market Share (%) By Region (2025-2032)

Table 128: North America Market Volume (K) (2025-2032) By Country

Table 129: North America Market Volume (K) (2025-2032) By Application

Table 130: North America Market Volume (K) (2025-2032) By Types

Table 131: Europe Market Volume (K) (2025-2032) By Country

Table 132: Europe Market Volume (K) (2025-2032) By Application

Table 133: Europe Market Volume (K) (2025-2032) By Types

Table 134: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 135: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 136: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 137: South America Market Volume (K) (2025-2032) By Country

Table 138: South America Market Volume (K) (2025-2032) By Application

Table 139: South America Market Volume (K) (2025-2032) By Types

Table 140: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 141: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 142: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 143: Research Programs/Design For This Report

Table 144: Key Data Information From Secondary Sources

Table 145: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Sampling Needle Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	430.00 million
Revenue forecast in 2033	749.94 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Roche; Lifescan; BD; Ascensia; Abbott; B. Braun; ARKRAY; Terumo; I-SENS; Nipro; Omron; AgaMatrix; Smiths Medical; Sarstedt; Sinocare; Yicheng; Yuwell; Greiner Bio One; Novo Nordisk; WEGO; Cardinal Health; KDL; Artsana; Ypsomed; Improve Medical
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers

Restraints

Opportunities

Challenges

Market Segmentation

Loading chart…

Sampling Needle Segmentation Breakdown8 items

Application

Hospitals

Diagnostic Centers

Others

Types

Vein Puncture Needle

Pricking Needle

Other

Regional Insights

Loading chart…

Competitive Landscape

BD leverages global GPO contracts and safety-engineered portfolio depth.

Terumo invests in Japanese precision tubing to support premium pricing.

Roche integrates sampling needles into point-of-care diagnostics ecosystems.

WEGO scales local manufacturing to win cost-driven provincial tenders.

KDL pursues vertical integration to mitigate stainless-steel price volatility.

Improve Medical expands CE-marked SKUs for EU pharmacy chains.

Key Sampling Needle Companies25 items

Roche

Lifescan

Ascensia

Abbott

B. Braun

ARKRAY

Terumo

I-SENS

Nipro

Omron

AgaMatrix

Smiths Medical

Sarstedt

Sinocare

Yicheng

Yuwell

Greiner Bio One

Novo Nordisk

WEGO

Cardinal Health

KDL

Artsana

Ypsomed

Improve Medical

Market Ecosystem

Speciality alloy mills — supply certified 304/316L and NiTi micro-bars with full melt traceability

Micro-tube drawing houses — convert bars into thin-wall cannula with ±0.01 mm tolerance

Needle set OEMs — integrate hubs, shields and safety mechanisms, then package in cleanrooms

Contract sterilisation providers — perform validated gamma or E-beam cycles and dose audits

Regional medical distributors — hold consignment inventories and deliver daily to hospital stockrooms

Clinical end users — laboratory phlebotomists, blood-bank technicians and interventional radiologists

Regulators and standards bodies — enforce ISO 9626, FDA 21 CFR §880.5860 and MDR technical files

Recent Industry Insights

Analyst Overview

Table of Contents